Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Alopecia is the medical term that is used to characterize the different types of hair loss from the scalp to the remainder of the body. Alopecia is usually categorized into two groups: non-scarring and cicatricial (also known as scarring). There are mainly four different patterns of hair loss associated with non-scarring alopecia: alopecia areata (AA), telogen effluvium, androgenetic alopecia (AGA), and trichotillomania (also known as physical alopecia). While there are off-label treatments used to manage AA, including systemic and localized therapies, there are no FDA-approved treatments for the condition.
The alopecia areata marketed and pipeline drugs assessment report provides a data-driven overview of the current and future competitive landscape in alopecia areata therapeutics.
Alopecia Areata Pipeline Drugs Market Overview by Mechanism of Action
The major pipeline drugs for treating AA are receptor agonist, receptor antagonist, enzyme inhibitor, protein & peptide inhibitor, and biological factor inhibitor.
Alopecia Areata Pipeline Drugs Market Analysis by Mechanism of Action
For more mechanism of action insights, download a free report sample
Alopecia Areata Pipeline Drugs Market Overview by Routes of Administration
The major pipeline drugs for treating AA are oral therapies, injections, and topical therapies.
Alopecia Areata Pipeline Drugs Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Market Report Scope
Major Mechanism of Action | Receptor Agonist, Receptor Antagonist, Enzyme Inhibitor, Protein & Peptide Inhibitor, and Biological Factor Inhibitor |
Major Routes of Administration | Oral Therapies, Injections, Topical Therapies |
Scope
GlobalData’s Alopecia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, and Route of Administration
- Product Profiles with Sales Forecast
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the alopecia market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global alopecia market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What are the major mechanisms of action in the alopecia areata pipeline drugs market?
The major pipeline drugs for treating alopecia areata are receptor agonist, receptor antagonist, enzyme inhibitor, protein & peptide inhibitor, and biological factor inhibitor.
-
What are the major routes of administration in the alopecia areata pipeline drugs market?
The major pipeline drugs for treating alopecia areata are oral therapies, injections, and topical therapies.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.